Invention Grant
- Patent Title: Methods of treating pruritic disease with IL-31 monoclonal antibodies
-
Application No.: US16834607Application Date: 2020-03-30
-
Publication No.: US11542327B2Publication Date: 2023-01-03
- Inventor: Kent Bondensgaard , Roland Beckmann
- Applicant: ZymoGenetics, Inc. , Merck Serono S/A
- Applicant Address: US NJ Princeton; CH Coinsins
- Assignee: ZymoGenetics, Inc.,Merck Serono S/A
- Current Assignee: ZymoGenetics, Inc.,Merck Serono S/A
- Current Assignee Address: US NJ Princeton; CH Coinsins
- Agent Brian J. Walsh
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/24 ; C12N15/63 ; C12N5/10
Abstract:
The invention provides humanized mouse anti-human IL-31 antibodies and antibody fragments that are capable of binding IL-31 and thereby neutralizing, inhibiting, limiting, or reducing the proinflammatory or pro-pruritic effects of IL-31.
Public/Granted literature
- US20200262913A1 METHODS OF TREATING PRURITIC DISEASE WITH IL-31 MONOCLONAL ANTIBODIES Public/Granted day:2020-08-20
Information query
